ADHD Linked to Increased Risk of Early Death, but Medication May Help

People diagnosed with attention-deficit/hyperactivity disorder (ADHD) face a significant increase in the risk of early death. According to a review published in JAMA Network Open, there is a 71% higher overall risk for those with ADHD compared to those without the condition. However, prescription ADHD medication may reduce this risk.

Study Overview

Researchers evaluated data from 19 observational studies, encompassing nearly 16 million individuals across three continents. The focus was on the long-term effects associated with ADHD.

Risk of Death

Both unnatural and natural causes of death were analyzed. Unnatural causes included injuries and suicide while natural causes encompassed health conditions like cardiovascular disease and diabetes. Those with ADHD showed elevated mortality rates across all categories. They faced nearly double the risk of death from suicide, with an 89% increase, and a 55% higher risk from injuries, such as motor vehicle accidents. Moreover, there was a 27% higher risk of death from natural causes.

Joshua Stott, a senior author and professor at University College London, highlighted the broad health inequalities faced by individuals with ADHD, noting risks not only from suicide and injury but also natural causes.

Factors Influencing Natural Causes

Long-term health risks like smoking and substance use contributed to increased deaths from natural causes. Challenges with executive function could hinder managing chronic conditions and adhering to treatment plans.

Medication Impact

Analysis showed that ADHD individuals taking prescribed medication had a 25% lower risk of death from any cause compared to those not on medication. This indicates that effective treatment potentially mitigates behavioral effects and health risks.

“ADHD is not a life-limiting condition by definition. The right support and treatment can enable individuals to lead long, healthy lives,” Stott stated.

Study Limitations and Call for Further Research

Researchers noted limitations in the study. All studies were observational, showing associations rather than direct causation. Medication findings were derived from only three studies, making them preliminary. Variations across studies in diagnostic criteria, healthcare access, and tracking methods were significant. Underlying factors like socioeconomic status and other health conditions were not uniformly controlled.

Lucy Corrigan, a first author and research assistant at the University of Liverpool, stated, “Findings suggest medication plays a key role in supporting ADHD health, though more research is necessary.” She emphasized that medication should be part of a comprehensive long-term treatment plan.

Khloe Quill is a lifestyle writer with Fox News Digital, focusing on topics like food, travel, and health.